Latest NBTX reports update at 2024-05-11: 2023 ∙ 2022 ∙ 2021

Nanobiotix S.A. NBTX

$ 6.67 -3.33%

Nanobiotix S.A. Balance Sheet 2011-2024 | NBTX

Annual Balance Sheet Nanobiotix S.A.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-80 M	2.53 M	-15.7 M	-42.5 M	-15.4 M	-12.4 M	-30.7 M	-3.9 M	-10.9 M	-76.3 K
Long Term Debt	-	-	-	39.1 M	37.6 M	20 M	3.96 M	4.58 M	3.53 M	-	875 K	1.07 M	527 K
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	44.5 M	-	20.4 M	4.19 M	4.76 M	3.7 M	2.31 M	975 K	1.17 M	573 K
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	63.6 M	58.1 M	32 M	13.5 M	13 M	10.8 M	6.74 M	4.26 M	3.33 M	1.99 M
Deferred Revenue	-	-	-	-	410 K	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-33.6 M	-50.9 M	-30.3 M	-26.1 M	-21.9 M	-17 M	-9.56 M	-8.14 M	-5.33 M	-5.25 M
Total Assets	93.9 M	59.8 M	102 M	134 M	56.2 M	46.2 M	57.5 M	30.4 M	26.4 M	37.1 M	7.44 M	14 M	2.91 M
Cash and Cash Equivalents	75.3 M	41.4 M	83.9 M	119 M	35.1 M	36.2 M	47.2 M	-	-	-	-	-	-
Book Value	-	-	102 M	70.5 M	-1.91 M	14.2 M	43.9 M	17.4 M	15.6 M	30.3 M	3.18 M	10.7 M	926 K
Total Shareholders Equity	-	-	-	70.5 M	-1.91 M	14.2 M	43.9 M	-	-	-	-	-	-

All numbers in EUR currency

Quarterly Balance Sheet Nanobiotix S.A.

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	38.1 M	-	44.4 M	-	44.5 M	-	-	-	43.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	102 M	-	124 M	-	134 M	-	-	-	56.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	83.9 M	-	102 M	-	119 M	-	26.6 M	-	35.1 M	-	-	-	36.2 M	-	-	-	47.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	102 M	-	124 M	-	134 M	-	-	-	56.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	26.8 M	-	41.4 M	-	70.5 M	-	-22.2 M	-	-1.91 M	-	-	-	14.2 M	-	-	-	43.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency